Logo Image
News
All NewsPractice Management
Media
All VideosExpert InterviewsPodcastsMedical World NewsPeer ExchangeInsightsCase StudiesCase of the QuarterClinical ForumsPractice OwnershipRapid ReadoutShortsVideo SeriesWhat’s Your WhEYE?
Conferences
Conference CoverageConference ListingConference Recaps
Blog
More
Publications
Digital EditionSupplements And Featured PublicationsiTech
Partners
Resources
Job BoardSponsored
CE

Subscribe

  • News
  • Media
  • Conferences
  • Blog
  • Publications
  • Partners
  • Resources
  • Subscribe
  • CE
  • AMD
  • Allergy
  • Blepharitis
  • COVID-19
  • Cataract
  • Comanagement
  • Comprehensive Eye Exams
  • Conjunctivitis
  • Contact Lenses
  • Cornea
  • DME
  • Diabetic Eye Disease
  • Dry Eye
  • Geographic Atrophy
  • Glasses
  • Glaucoma
  • LASIK
  • Lens Technology
  • Lid and Lash
  • Myopia
  • Nutrition
  • OCT
  • Ocular Surface Disease
  • Optic Relief
  • Patient Care
  • Pediatrics
  • Presbyopia
  • Ptosis
  • Refractive Surgery
  • Retina
  • Technology
  • Therapeutic Cataract & Refractive
Spotlight -
Geographic Atrophy|
Myopia
Advertisement

Diana Do, MD

Advertisement

Articles by Diana Do, MD

Achieving improved outcomes through partnerships between optometrists and retina specialists

ByA. Paul Chous, OD, MA, FAAO,W. Lloyd Clark, MD,Diana Do, MD,Mark T. Dunbar, OD, FAAO,Steven Ferrucci, OD, FAAO,Nancy Holekamp, MD,Ehsan Rahimy, MD,Leo P. Semes, OD, FAAO,Charles Wykoff, MD, PHD
November 1st 2020

Sponsored Content

Considerations in the treatment of diabetic retinopathy and diabetic macular edema.

Advertisement

Latest Updated Articles

  • Achieving improved outcomes through partnerships between optometrists and retina specialists
    Achieving improved outcomes through partnerships between optometrists and retina specialists

    November 1st 2020



Advertisement
Advertisement

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

1

AAOpt 2026: Demodex tied to worse MGD as dry eye questionnaires miss blepharitis

2

AAOpt 2026: Aflibercept 8 mg extends RVO dosing as Amsler misses AMD damage

3

AAOpt 2026: The real-world impact of treatment switch to latanoprostene bunod

4

The patient who could not scroll: When prism became the practical solution

5

AAOpt 2026: Insights into perimenopause and presbyopia

  • Advertise
  • About Us
  • Editorial
  • Contact Us
  • Job Board
  • Terms & Conditions
  • Privacy
  • Do not sell my Information
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

  • Ophthalmology Times
  • Modern Retina
  • Optometry Times
  • Ophthalmology Times Europe
Collaborative Care Symposium
Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us